Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1982 Mar 1;155(3):872-83.
doi: 10.1084/jem.155.3.872.

Features of T cells causing H-2-restricted lethal graft-vs.-host disease across minor histocompatibility barriers

Features of T cells causing H-2-restricted lethal graft-vs.-host disease across minor histocompatibility barriers

R Korngold et al. J Exp Med. .

Abstract

Evidence is presented that T cells that produce lethal graft-vs.-host disease (GVHD) to minor histocompatibility antigens (minor HA) comprise discrete subgroups of H-2K- and H-2D-restricted T cells; double negative selection of T cells in irradiated H-2 recombinant mice was used to separate these two subgroups. No evidence could be found that I-restricted T cells contributed to GVHD, either as effector cells or helper cells. The (unprimed) precursor cells for GVHD expressed the Thy-1+, Lyt-1+/-2, Ia- phenotype. Studies in which H-2-semiallogeneic bone marrow chimeras were used as hosts for negative selection suggested that presentation of minor HA to T cells during the induction phase is controlled by marrow-derived cells; indirect evidence was obtained that these latter cells can "process" minor HA presented on H-2 different cells and thereby render the antigens immunogenic. Studies in which minor HA-different, H-2-compatible chimeras were re-irradiated and then injected with donor-vs.-host T cells suggested that the effector phase of lethal GVHD involves contact of antigen on non-marrow-derived cells.

PubMed Disclaimer

Similar articles

Cited by

References

    1. J Exp Med. 1972 Aug 1;136(2):331-43 - PubMed
    1. J Immunol. 1973 Aug;111(2):575-89 - PubMed
    1. J Exp Med. 1973 Nov 1;138(5):1213-29 - PubMed
    1. Prog Allergy. 1971;15:78-187 - PubMed
    1. J Exp Med. 1975 Dec 1;142(6):1349-64 - PubMed

Publication types